Evidence map›Paper›PMID 33386508›Full record

Trial reportAIDS and behavior2021

Efficacy, Use, and Usability of the VIP-HANA App for Symptom Self-management in PLWH with HANA Conditions.

Rebecca Schnall, Tiffany Porras, Hwayoung Cho, Haomiao Jia, Karolynn Siegel, David C Mohr, Suzanne Bakken, Susan Olender

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in AIDS and behavior, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Feasibility of the Adapted MyPEEPS Mobile App for HIV Prevention in Young Transgender Men.AIDS education and prevention : official publication of the International Society for AIDS Education · 2025
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Rebecca SchnallDivision of Scholarship and Research, Columbia University School of Nursing, 560 West 168th Street, New York, NY, 10032, USA. rb897@columbia.edu.ORCID http://orcid.org/0000-0003-2184-4045
Tiffany PorrasDivision of Scholarship and Research, Columbia University School of Nursing, 560 West 168th Street, New York, NY, 10032, USA.
Hwayoung ChoUniversity of Florida College of Nursing, Gainesville, FL, USA.
Haomiao JiaDivision of Scholarship and Research, Columbia University School of Nursing, 560 West 168th Street, New York, NY, 10032, USA.
Karolynn SiegelSociomedical Sciences, Columbia University Mailman School of Public Health, New York, NY, USA.
David C MohrCenter for Behavioral Intervention Technologies (CBITs), Preventive Medicine, Medical Social Sciences and Psychiatry and Behavioral Sciences, Northwestern University, Chicago, IL, USA.
Suzanne BakkenDivision of Scholarship and Research, Columbia University School of Nursing, 560 West 168th Street, New York, NY, 10032, USA.
Susan OlenderDivision of Infectious Disease, Columbia University Medical Center, New York, NY, USA.
Columbia University · USColumbia University Irving Medical Center · USNorthwestern University · USUniversity of Florida · US

Funding

Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) SymptomsR01NR015737 · NINR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SCHNALL, REBECCA · 2015 to 2019
$2.8M
Mentoring and Research in Self-Management for Health Promotion and Disease PreventionK24NR018621 · NINR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SCHNALL, REBECCA · 2019 to 2022
$384k
NIH HHS K24NR018621NINR NIH HHS K24 NR018621NINR NIH HHS R01 NR015737NINR NIH HHS R01NR015737
6 · The paper itself

Abstract

The purpose of this study was to evaluate the efficacy of the VIP-HANA application (app) for improving symptom burden in a randomized control trial of 100 people living with HIV (PLWH) who have non-AIDS conditions associated with HIV. The intervention group received the VIP-HANA app which allowed them to report their symptoms every week and receive self-management strategies tailored to their symptoms. The control arm received an app to report their symptoms every week but did not receive any strategies. The results of our study suggest that symptom burden improved in the participants of both study arms. Although these findings do not support the efficacy of VIP-HANA in improving symptom burden in PLWH who have HIV-associated non-AIDS (HANA) conditions, this could be a function of the study design. Findings suggest that PLWH are interested in monitoring their symptoms, which could have implications for the wider use of digital health for patient surveillance.

Indexed as

HIV InfectionsMobile ApplicationsSelf-ManagementTelemedicineHumansResearch DesignCo-morbid conditionsHIVmHealthMobile appsUsability

Identifiers

PMID33386508
PMCPMC8084885
OpenAlexW3114583156

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.